Risk stratification in hypertension: new insights from the Framingham Study.
暂无分享,去创建一个
[1] W. Kannel,et al. The prognostic significance of proteinuria: the Framingham study. , 1984, American heart journal.
[2] R. D'Agostino,et al. Use of vital capacity for cardiac failure risk estimation in persons with coronary disease and left ventricular hypertrophy. , 1996, The American journal of cardiology.
[3] D. Levy,et al. Profile for estimating risk of heart failure. , 1999, Archives of internal medicine.
[4] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.
[5] R B D'Agostino,et al. Influence of heart rate on mortality among persons with hypertension: the Framingham Study. , 1993, American heart journal.
[6] E. Bonora,et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. , 1989, The New England journal of medicine.
[7] D. Levy,et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.
[8] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[9] G. Reaven,et al. Insulin resistance, its consequences, and coronary heart disease. Must we choose one culprit? , 1996, Circulation.
[10] L. Kuller,et al. A historical perspective of elevated systolic vs diastolic blood pressure from an epidemiological and clinical trial viewpoint. , 1989, Journal of clinical epidemiology.
[11] E. Lew. High blood pressure, other risk factors and longevity: the insurance viewpoint. , 1973, The American journal of medicine.
[12] M. Shipley,et al. Systolic and diastolic blood pressures as predictors of coronary heart disease mortality in the Whitehall study. , 1985, British medical journal.
[13] J Lubitz,et al. Benefit of a favorable cardiovascular risk-factor profile in middle age with respect to Medicare costs. , 1998, The New England journal of medicine.
[14] Detection. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .
[15] W. Wilkinson,et al. Logistic model estimation of death attributable to risk factors for cardiovascular disease in Evans County, Georgia. , 1980, American journal of epidemiology.
[16] J. Cutler,et al. Controlled Clinical Trials of Drug Treatment for Hypertension A Review , 1989, Hypertension.
[17] R B D'Agostino,et al. Probability of stroke: a risk profile from the Framingham Study. , 1991, Stroke.
[18] D. Levy,et al. Population implications of electrocardiographic left ventricular hypertrophy. , 1987, The American journal of cardiology.
[19] R. Gubner. Systolic hypertension: a pathogenetic entity. Significance and therapeutic considerations. , 1962, The American journal of cardiology.
[20] R B D'Agostino,et al. Intermittent claudication. A risk profile from The Framingham Heart Study. , 1997, Circulation.
[21] B. Psaty,et al. Cost-minimization and the number needed to treat in uncomplicated hypertension. , 1998, American journal of hypertension.
[22] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.